|Recommendation and use
- In May 2009, WHO announced that NECT had been included on the Essential Medicines List (EML).
- In July 2009, the Democratic Republic of Congo ordered the first NECT kits to treat patients.
- In 2010, 9 other African countries ordered NECT.
- Congo, Equatorial Guinea, the Republic of Congo and Guinea Conakry signed a request for supply in 2011.
- Added to the Essential Medicines List for children (EMLc) of the WHO in 2013
- In 2014, Nigeria approved NECT
A pivotal clinical trial study called NECT-Field is currently ongoing to complete the safety and effectiveness profile of NECT. It will use a sampling target of a minimum of 620 patients that will be followed for 24 months and test for the first time the treatment on special populations such as children and pregnant or breastfeeding women.The study will also document the feasibility of the implementation of NECT and determine the minimum standards of care required.